A Phase II Multi-institutional Study Assessing Simultaneous In-Field Boost Helical Tomotherapy for 1-3 Brain Metastases
Interventional
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Overall survival
At approximately end of year 4 (study completion)
No
George Rodrigues, MD, MSc
Principal Investigator
London Regional Cancer Program of the Lawson Health Research Institute
Canada: Ethics Review Committee
R-10-204
NCT01543542
April 2010
April 2014
Name | Location |
---|